Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. 

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.  

Faculty Disclosures

Ana Berlin, MD, FACS - Nothing to disclose 
Melissa Red Hoffman, MD, FACS - Nothing to disclose 
Tonia Young-Fadok, MD, FACS - Nothing to disclose
John A. Harvin, MD, FACS - Nothing to disclose
Jonah J. Stulberg, Md, PhD, MPH, FACS - Nothing to disclose
Bridget Fahy, MD, FACS - Nothing to disclose

• Screen for chronic pain and opioid tolerance and integrate medical reconciliations into a safe pain management plan for patients.
• Better manage perioperative pain in patients who take chronic opioids or those on medication-assisted treatment by using both pharmacologic and non-pharmacologic adjuncts and by adjusting short-acting opioid doses to account for opioid tolerance.
• Outline the diagnostic criteria for opioid use disorder (OUD) as well as explain how buprenorphine and methadone are used to manage OUD.
• Describe strategies for patients and caregivers including expectation management to promote safe and effective management of pain related to surgical illnesses in patients with opioid tolerance or elevated risk of opioid misuse.
• Explain how team training can help minimize postoperative pain.
• Identify ERAS components that can help minimize patient pain and anxiety along the surgical continuum (ie, pre-op, post-op/recovery).

Contact

• For questions about the educational activity, please contact Kathleen Maruyama at kmaruyama@facs.org.

• For technical questions, please contact Learning@facs.org.

This activity is intended for surgeons and members of the surgical team (preoperative, intraoperative, and postoperative).

CME Credit Claiming Information

In order to claim a CME Certificate or a Certificate of Completion, the following requirements will need to be completed in the course:

• Review all course materials
• Complete the post test
• Course evaluation

Participants may only claim a maximum of 2.00 AMA PRA Category 1 Credits™ for this activity.